About VeGen
VeGen is a company based in Hyderabad (India) founded in 2021 by Prashant Bhavar and Uday Kumar. VeGen operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Hyderabad, India
- Founders Prashant Bhavar, Uday Kumar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vegen Labs Llp
- Date of Incorporation 30 Jun, 2021
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$36.24 K (USD)127as on Mar 31, 2024
-
Net Profit
-$1.05 K (USD)-360as on Mar 31, 2024
-
EBITDA
-$945.48 (USD)-749as on Mar 31, 2024
-
Latest Funding Round
$430.41 K (USD), Grant
Mar 03, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of VeGen
Investors in VeGen
VeGen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BIRAC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Business incubation services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for VeGen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VeGen
Investment portfolio details for VeGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VeGen
Detailed financials for VeGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vegen Comparisons
Peer comparison for VeGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VeGen
VeGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of VeGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vegen
Complete news archive for VeGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VeGen
VeGen was founded in 2021 and raised its 1st funding round 4 years after it was founded.
VeGen is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of VeGen is $36.24K as on Mar 31, 2024.
VeGen was founded in 2021 and is based in Hyderabad, India. Therapeutics for cancer patients are developed by the company within the biotechnology sector. A pipeline of drug candidates is maintained, including IND126 targeted at lung cancer and colorectal cancer, KRAS12D for pancreatic cancer, and additional candidates. Operations focus on advancing these treatments through research and development stages.
VeGen's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
VeGen has 1 investor. Key investors include BIRAC.